Pfizer's stock is poised for growth due to its strong pipeline, smart cost management, and recovery from COVID-19 revenue ...
Pfizer stock slipped about 0.7% to $25.19 after The Wall Street Journal reported on an inquiry looking into the suggestion ...
2d
Zacks Investment Research on MSNPfizer Is a Dirt-Cheap High-Yield Stock, But Is It a Buy?Of late, pharmaceutical behemoth Pfizer Inc.’s PFE stock has struggled, but it remains a bargain with generous dividends. Its ...
Pfizer's stock has recently struggled but remains a bargain with generous dividends. Is now a good time to invest in PFE?
Here are three reasons why Pfizer could prove to be a steal of a deal this year. Buying quality stocks at decent valuations ...
Shares of Pfizer Inc. PFE slipped 1.33% to $25.21 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 1.12% to 5,712.20 and Dow ...
We recently published a list of 14 Best Affordable Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Pfizer stock has delivered its long-term shareholders a dividend that has grown for 16 consecutive years. The pace of those ...
Pfizer's attractive dividend yield and low P/E ratio make it appealing. Learn why PFE stock's valuation risks may be higher ...
Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results